article thumbnail

PO-03-070 RISK OF THROMBOEMBOLISM AFTER COVID-19 VACCINATION IN PATIENTS WITH ATRIAL FIBRILLATION/ATRIAL FLUTTER: A SELF-CONTROLLED CASE-SERIES STUDY

HeartRhythm

Concerns about the safety of coronavirus disease (COVID-19) vaccines in patients with atrial fibrillation/atrial flutter (AF/AFL) have arisen due to reports of an association between thromboembolic events and COVID-19 vaccination.

article thumbnail

Prospective arrhythmia surveillance after a COVID-19 diagnosis

Open Heart

Background Cardiac arrhythmias have been observed among patients hospitalised with acute COVID-19 infection, and palpitations remain a common symptom among the much larger outpatient population of COVID-19 survivors in the convalescent stage of the disease. Median monitoring duration was 13.2 (IQR

article thumbnail

Digitally enabled acute care for atrial fibrillation: conception, feasibility and early outcomes of an AF virtual ward

Open Heart

Virtual wards could be the way forward to manage acute AF patients through remote monitoring, especially with the rise in global access to digital telecommunication and the growing acceptance of telemedicine post-COVID-19. Methods An AF virtual ward was implemented as a proof-of-concept care model.